NCT06464770 Optimizing Infection Prophylaxis Prior to Shoulder Surgery
| NCT ID | NCT06464770 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Washington |
| Condition | Arthroplasty Shoulder |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2024-08-31 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2024-08-31 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this interventional study is to determine the amount of skin C. acnes reduction with increased pressure during the chlorhexidine gluconate, brand name ChloraPrep, application. The main question it aims to answer is: Does changing the pressure applied during the ChloraPrep application impact the amount of C. acnes bacteria on the skin after one hour? Researchers will compare ChloraPrep applied at a pressure similar to a gentle wipe to ChloraPrep applied at a pressure similar to a massage to see if wash the amount of C. acnes on the skin after one hour is different. Participants will have one shoulder washed with ChloraPrep using pressure meant to impact the dermal layer, similar to a gentle wipe, and the other shoulder washed with ChloraPrep using pressure meant to impact the subdermal layer, similar to a massage. Participants will have swabs taken of their skin before the ChloraPrep application and again one hour after application to look for the amount of C. acnes on the skin.
Eligibility Criteria
Inclusion Criteria: * English speaking Exclusion Criteria: * Self report very sensitive skin * Allergic to chlorhexidine * Used antibiotics in the last three months * Used acne treatment in the last three months * Wounds on your shoulders
Contact & Investigator
Jason Hsu, MD
PRINCIPAL INVESTIGATOR
University of Washington
Frequently Asked Questions
Who can join the NCT06464770 clinical trial?
This trial is open to male participants only, aged 18 Years or older, up to 89 Years, studying Arthroplasty Shoulder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06464770 currently recruiting?
Yes, NCT06464770 is actively recruiting participants. Contact the research team at whitsa@uw.edu for enrollment information.
Where is the NCT06464770 trial being conducted?
This trial is being conducted at Seattle, United States.
Who is sponsoring the NCT06464770 clinical trial?
NCT06464770 is sponsored by University of Washington. The principal investigator is Jason Hsu, MD at University of Washington. The trial plans to enroll 40 participants.